Legionnaires' disease (Q34487838)

2 August 2017

1 reference

title

Legionnaires' disease. (English)

1 reference

2 August 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231463%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Emilio Bouza

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231463%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

1

Burke A Cunha

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231463%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

language of work or name

English

0 references

publication date

28 July 2015

1 reference

2 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231463%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

volume

387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231463%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

issue

10016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231463%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

page(s)

376-385

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231463%20AND%20SRC:MED&resulttype=core&format=json

Legionnaires' disease: description of an epidemic of pneumonia

15 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Identification of legionella in clinical samples.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Typing methods for legionella.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Monoclonal antibody reactivity as a virulence marker for Legionella pneumophila serogroup 1 strains

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Legionella pneumophila urinary antigen subtyping using monoclonal antibodies as a tool for epidemiological investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

The use of 16S ribosomal RNA analyses to investigate the phylogeny of the family Legionellaceae

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Sequence-based identification of legionella

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Can Legionnaires disease be diagnosed by clinical criteria? A critical review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Severe Legionella pneumonia: rapid presumptive clinical diagnosis with Winthrop-University Hospital's weighted point score system (modified)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Legionnaires' disease: clinical differentiation from typical and other atypical pneumonias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Comparative study of Legionella pneumophila and other nosocomial-acquired pneumonias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

The radiologic manifestations of Legionnaire's disease. The Ohio Community-Based Pneumonia Incidence Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Legionella community-acquired pneumonia (CAP) presenting with spontaneous bilateral pneumothoraces

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Lung abscess caused by Legionella species: implication of the immune status of hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Spontaneous rupture of the spleen in a patient with legionellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Legionella pneumophila pericarditis proved by culture of pericardial fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Myocarditis: a rare complication during Legionella infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Legionella micdadei, a new cause of prosthetic joint infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Legionella brain stem encephalopathy and peripheral neuropathy without preceding pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Legionnaires' disease and brain abscess

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Relapse of infection in an immunocompromised patient

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

1 reference

7 January 2021

Increase in pre-seasonal community-acquired Legionnaire's disease due to increased precipitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Rainfall is a risk factor for sporadic cases of Legionella pneumophila pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

On-site availability of Legionella testing in acute care hospitals, United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Pan-European Study on Culture-Proven Legionnaires' Disease: Distribution of Legionella pneumophila Serogroups and Monoclonal Subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Prevalence of sequence types among clinical and environmental isolates of Legionella pneumophila serogroup 1 in the United States from 1982 to 2012.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Distribution of Legionella pneumophila serogroups, monoclonal antibody subgroups and DNA sequence types in recent clinical and environmental isolates from England and Wales (2000-2008).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Sporadic legionellosis in the United States: the first thousand cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Nosocomial Legionnaires' disease. Occurrence in recipients of bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Severe Legionella pneumophila infection in a patient with hairy cell leukemia in partial remission after alpha interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Opportunistic Lung Infection Due to “Pittsburgh Pneumonia Agent”

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Prevention of Legionnaires' disease in transplant recipients: recommendations for a standardized approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Legionella pneumonia and HIV: case reports and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Measure ofLegionella pneumophila activity in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Legionella and Legionnaires' disease: 25 years of investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Resuscitation of viable but nonculturable Legionella pneumophila Philadelphia JR32 by Acanthamoeba castellanii

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Ubiquitousness of Legionella pneumophila in the water supply of a hospital with endemic Legionnaires' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Assessing risk of health care-acquired Legionnaires' disease from environmental sampling: the limits of using a strict percent positivity approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Legionellosis: evidence of airborne transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Nosocomial legionellosis in surgical patients with head-and-neck cancer: implications for epidemiological reservoir and mode of transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Control of endemic nosocomial Legionnaires' disease by using sterile potable water for high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Isolation of Legionella longbeachae serogroup 1 from potting mixes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Does using potting mix make you sick? Results from a Legionella longbeachae case-control study in South Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Urine Antigen Tests Positive for Pontiac Fever: Implications for Diagnosis and Pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Preliminary report on the pathogenicity of Legionella pneumophila for freshwater and soil amoebae

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Molecular pathogenesis of infections caused by Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Update on Legionnaires' disease: pathogenesis, epidemiology, detection and control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Systematic review and metaanalysis: urinary antigen tests for Legionellosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Sensitivity of three urinary antigen tests associated with clinical severity in a large outbreak of Legionnaires' disease in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

A large, travel-associated outbreak of legionellosis among hotel guests: utility of the urine antigen assay in confirming Pontiac fever.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Application of Legionella pneumophila-specific quantitative real-time PCR combined with direct amplification and sequence-based typing in the diagnosis and epidemiological investigation of Legionnaires' disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Impact of routine systematic polymerase chain reaction testing on case finding for Legionnaires' disease: a pre-post comparison study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Comparison of sputum and nasopharyngeal swab specimens for molecular diagnosis of Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Design and implementation of a protocol for the detection of Legionella in clinical and environmental samples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Culturing, media, and handling of legionella

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Community-acquired legionnaires disease: implications for underdiagnosis and laboratory testing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Antimicrobial chemotherapy for legionnaires' disease: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Application of the Etest to antimicrobial susceptibility testing of Legionella spp

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

The effect of inoculum, culture medium and antimicrobial combinations on the in-vitro susceptibilities of Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

In vitro activity of azithromycin against clinical isolates of Legionella species

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Effect of monensin on the invasiveness and multiplication of Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Isolation of ciprofloxacin-resistant Legionella pneumophila in a patient with severe pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Investigation of outbreaks: epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Outbreak investigations and identification of legionella in contaminated water

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Identification of legionella in the environment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Specific real-time PCR for simultaneous detection and identification of Legionella pneumophila serogroup 1 in water and clinical samples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Addition of neuA, the gene encoding N-acylneuraminate cytidylyl transferase, increases the discriminatory ability of the consensus sequence-based scheme for typing Legionella pneumophila serogroup 1 strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

A hospital-associated outbreak of Legionnaires' disease caused by Legionella pneumophila serogroups 4 and 10 with a common genetic fingerprinting pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Prevention of hospital-acquired legionellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Clinical Efficacy of Moxifloxacin Versus Comparator Therapies for Community-Acquired Pneumonia Caused byLegionellaspp

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

In vitro activity of antimicrobial agents against Legionella isolated from environmental water systems: first results from Turkey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

In Vitro Intracellular Activity and In Vivo Efficacy of Modithromycin, a Novel Bicyclolide, against Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Treatment strategies for Legionella infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

An update on Legionella.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Primary care summary of the British Thoracic Society Guidelines for the management of community acquired pneumonia in adults: 2009 update. Endorsed by the Royal College of General Practitioners and the Primary Care Respiratory Society UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Levofloxacin efficacy in the treatment of community-acquired legionellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Antimicrobial Chemotherapy for Legionnaires Disease: Time for a Change

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Delay in appropriate therapy of Legionella pneumonia associated with increased mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Outbreak of Legionnaires' disease in immunosuppressed patients at a cancer centre: usefulness of universal urine antigen testing and early levofloxacin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Interactions between tacrolimus and antimicrobial agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Consideration of prophylactic antibiotic therapy during an outbreak of Legionnaires' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

Experiences of the first 16 hospitals using copper-silver ionization for Legionella control: implications for the evaluation of other disinfection modalities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960078-2

7 January 2021

10.1016/S0140-6736(15)60078-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26231463%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

1 reference